Consult an Expert
Trademark
Design Registration
Consult an Expert
Trademark
Copyright
Patent
Infringement
Design Registration
More
Consult an Expert
Consult an Expert
Trademark
Design Registration
Login
ADAPTIVE SYSTEM FOR PREDICTION OF MUCORMYCOSIS SEVERITY WITH EXPLAINABLE AI AND INTEGRATED CLINICAL DECISION SUPPORT
Extensive patent search conducted by a registered patent agent
Patent search done by experts in under 48hrs
₹999
₹399
Abstract
Information
Inventors
Applicants
Specification
Documents
ORDINARY APPLICATION
Published
Filed on 28 October 2024
Abstract
A system for predicting mucormycosis severity(100), consists of a modules for acquiring clinical data(101), analysing the data(102), explainability module for generating human-interpretable insights into the machine learning model's predictions(103), A decision support module for providing risk stratification and treatment recommendations based on the model’s output(104).
Patent Information
Application ID | 202441082282 |
Invention Field | BIO-MEDICAL ENGINEERING |
Date of Application | 28/10/2024 |
Publication Number | 45/2024 |
Inventors
Name | Address | Country | Nationality |
---|---|---|---|
Kavitha U | Assistant professor Department of Computer Science & Engineering(Data Science) New Horizon College of Engineering New Horizon Knowledge ParkOuter Ring Road, Near Marathalli, Bellandur(P), Bangalore-560103 | India | India |
Applicants
Name | Address | Country | Nationality |
---|---|---|---|
New Horizon College of Engineering | New Horizon College of Engineering New Horizon Knowledge Park Outer Ring Road, Near Marathalli Bellandur(P), Bangalore-560103 | India | India |
Specification
Description:The invention provides a novel method for predicting the severity of mucormycosis disease by leveraging machine learning (ML) and explainable artificial intelligence (XAI). An AI-driven system is utilized to analyze clinical data to identify patterns predictive of disease progression. Unlike traditional diagnostic methods, which rely on clinical suspicion or invasive testing, this invention enables early detection, aiding in timely and accurate intervention.
The system consists of a machine learning model designed to process a wide array of clinical data collected from both individual patients and larger populations. The input data includes, but is not limited to previous medical conditions like diabetes, cancer, immunosuppressive treatments,comorbidities,laboratory results,symptoms and Demographic Data like Age, sex, geographic location, and environmental exposure. , Claims:1.A system for predicting mucormycosis severity(100), comprising modules for acquiring clinical data(101), analysing the data(102), explainability module for generating human-interpretable insights into the machine learning model's predictions(103), A decision support module for providing risk stratification and treatment recommendations based on the model's output(104).
2.A system for predicting mucormycosis severity(100)of claim 1, wherein the data collection module(201) integrates patient history, lab results, demographics, and imaging data from electronic health records.
3.A system for predicting mucormycosis severity(100) of claim 1, wherein the explainable AI techniques(301) include SHAP values or LIME to provide a visual explanation of the factors contributing to the prediction of mucormycosis severity.
4.A system for predicting mucormycosis severity(100) as claimed in claim 1 wherein the computer readable medium(401) storing instructions for executing the method, wherein the machine learning model is configured to continuously update its predictive capacity by learning from new patient data.
Documents
Name | Date |
---|---|
202441082282-FORM-9 [04-11-2024(online)].pdf | 04/11/2024 |
202441082282-COMPLETE SPECIFICATION [28-10-2024(online)].pdf | 28/10/2024 |
202441082282-DRAWINGS [28-10-2024(online)].pdf | 28/10/2024 |
Talk To Experts
Calculators
Downloads
By continuing past this page, you agree to our Terms of Service,, Cookie Policy, Privacy Policy and Refund Policy © - Uber9 Business Process Services Private Limited. All rights reserved.
Uber9 Business Process Services Private Limited, CIN - U74900TN2014PTC098414, GSTIN - 33AABCU7650C1ZM, Registered Office Address - F-97, Newry Shreya Apartments Anna Nagar East, Chennai, Tamil Nadu 600102, India.
Please note that we are a facilitating platform enabling access to reliable professionals. We are not a law firm and do not provide legal services ourselves. The information on this website is for the purpose of knowledge only and should not be relied upon as legal advice or opinion.